Stanley-Laman Group, Ltd. - LOGICBIO THERAPEUTICS INC ownership

LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 41 filers reported holding LOGICBIO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Stanley-Laman Group, Ltd. ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$211,000
-16.9%
19,5300.0%0.05%
-14.8%
Q2 2019$254,00019,5300.06%
Other shareholders
LOGICBIO THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Orbimed Advisors 6,466,783$69,906,0001.33%
Board of Trustees of The Leland Stanford Junior University 949,443$10,264,0001.11%
Lion Point Capital, LP 500,000$5,405,0000.60%
Sio Capital Management, LLC 122,536$1,325,0000.43%
Redmile Group, LLC 749,026$8,097,0000.27%
SAMLYN CAPITAL, LLC 639,977$6,918,0000.17%
Stanley-Laman Group, Ltd. 19,530$211,0000.05%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,378,475$14,901,0000.04%
FRANKLIN RESOURCES INC 700,000$7,567,0000.00%
Jefferies Group LLC 10,618$115,0000.00%
View complete list of LOGICBIO THERAPEUTICS INC shareholders